Edwards Lifesciences Corp (NYSE:EW)

90.42
Delayed Data
As of May 10
 -1.75 / -1.90%
Today’s Change
66.23
Today|||52-Week Range
98.11
-0.89%
Year-to-Date
White Lighthouse Investment Management Inc. ...
May 10 / GuruFocus News - Paid Partner Content
Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $3.3 million of Shares
May 05 / GuruFocus News - Paid Partner Content
Top Research Reports for JPMorgan, Home Depot & Merck
May 07 / Zacks.com - Paid Partner Content
Abiomed to Shareholders: Patience Please, Growth Is On The Way.
May 04 / MotleyFool.com - Paid Partner Content
Suncoast Equity Management Buys Regeneron Pharmaceuticals Inc, T. ...
May 06 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close92.17
Today’s open92.42
Day’s range90.26 - 92.42
Volume2,356,494
Average volume (3 months)2,688,483
Market cap$57.3B
Data as of 4:00pm ET, 05/10/2021

Growth & Valuation

Earnings growth (last year)-21.06%
Earnings growth (this year)+18.78%
Earnings growth (next 5 years)+14.57%
Revenue growth (last year)+0.88%
P/E ratio67.0
Price/Sales13.14
Price/Book12.58

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC-0.55-1.25%
SYKStryker Corp+1.12+0.44%
STESteris plc-3.85-1.82%
ISRGIntuitive Surgical-22.31-2.60%
Data as of 4:00pm ET, 05/10/2021

Financials

Next reporting dateJuly 27, 2021
EPS forecast (this quarter)$0.55
Annual revenue (last year)$4.4B
Annual profit (last year)$823.4M
Net profit margin18.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Irvine, California

Forecasts